Table 1. Clinical features of the HT patients and healthy controls included in the study.
HT patients | Healthy controls | Range | P-values | |
---|---|---|---|---|
Number | 28 | 20 | ||
Gender (M/F) | 5/23 | 3/17 | ||
Age (year) | 42 ± 15 | 42 ± 8 | 0.98 | |
FT3 (pmol/liter) | 4.87 ± 0.64 | 4.99 ± 0.56 | 3.1–6 | 0.51 |
FT4 (pmol/liter) | 10.42 ± 2.36 | 10.72 ± 1.36 | 7.86–17.41 | 0.61 |
TSH (uIU/ml) | 7.26 ± 11.26 | 1.98 ± 0.94 | 0.34–5.6 | <0.05 |
TgAb (IU/ml) | 162.6 ± 349.9 | 0.3 ± 1.0 | 0–4 | <0.05 |
TPOAb (IU/ml) | 570.3 ± 883.5 | 0.6 ± 0.5 | 0–9 | <0.01 |
Data correspond to the arithmetic mean ± SD and were compared using unpaired t-tests. M: male; F: female.